Here are relevant reports on : e-commerce-market-research
-
OpenStack Service Market by Component (Solution, Service), Organization Size (Large Enterprises, Small & Medium Enterprises), Vertical (IT, Telecommunication, Academic & Research, BFSI, Retail & E-Commerce), and Region - Global Forecast to 2022
The OpenStack service market is projected to grow from USD 1.63 Billion in 2017 to USD 5.66 Billion by 2022, at a CAGR of 28.3% from 2017 to 2022. Fast and easy deployment, no compulsion of vendor lock-in, and advantage of wide community support are the factors driving the growth of the OpenStack service market across the globe. The ecosystem of the OpenStack service market includes key players such as Canonical (UK), Huawei (China), Cisco Systems (US), SUSE (Germany), VMware (US), HPE (US), Oracle (US), Dell EMC (US), IBM (US), Red Hat (US), Rackspace (US), Mirantis (US), Platform9 Systems (US), EasyStack (China), and Bright Computing (US), which offer OpenStack solutions and services.
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Social Commerce, F-Commerce Market - Customer Buying Trends, emerging platforms, Geographical analysis, Investments and worldwide Market Forecasts (2013 - 2018)
Although social networking and e-commerce have long been in existence, there exists an evolving need for restructuring the two. The merger of these industries has taken the market by storm and is expected to impact the industry profoundly, in the years to come. While both these markets are in their early maturation phases; the combination of these solutions is bound to propel their growth. While social media is rigorously growing beyond advertisements; social commerce is on the brink of expanding beyond an alternative mechanism for payments.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cross-Border E-Commerce Logistics Software Market - Global Forecast to 2029
The cross-border e-commerce logistics software market will grow from USD xx billion in 2024 to USD xx billion by 2029 at a compounded annual growth rate (CAGR) of xx% during the forecast period. The increasing globalization and adoption of online retail, driven by consumer demand for foreign goods and more seamless shopping experiences, is driving the adoption of cross-border e-commerce logistics software.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
North America Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)-Forecast to 2030
The North America biomarkers market is projected to reach USD 42.25 billion by 2030 from USD 25.13 billion in 2025, at a CAGR of 11.0% during the forecast period. The Key Players include Abbott (US), Thermo Fisher Scientific Inc (US), Revvity (US), Laboratory Corporation Of America Holdings (US), Charles River Laboratories (US), Bio-Rad Laboratories, Inc (US), Agilent Technologies, Inc (US), Quanterix (US)
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers market is projected to reach USD 28.11 billion by 2030 from USD 17.46 billion in 2025, at a CAGR of 10.0% during the forecast period. The Key Players include F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), QIAGEN (Germany), Eurofins Scientific (Luxembourg), bioMérieux (France), R-Biopharm AG (Germany), Synexa Life Sciences BV (Netherlands), Proteome Sciences (UK).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers market is projected to reach USD 26.40 billion by 2030 from USD 14.73 billion in 2025, at a CAGR of 12.4% during the forecast period. The Key players include Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), QIAGEN (Germany), JSR Corporation (Japan), WuXi AppTec (China), among others.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
